Speciallægeselskabet Københavns Smerteklinik ApS
CVR: 40180087
The financial health of Speciallægeselskabet Københavns Smerteklinik ApS appears to be under pressure, as indicated by a decline in profitability, reporting a loss of 12,505 DKK in 2024 after a profit of 15,662 DKK in 2023. Revenue for 2024 stands at 2,662,649 DKK, marking the first recorded revenue, but overall profit has fluctuated significantly over the past few years, with a peak profit of 225,210 DKK in 2022. The company's equity has decreased slightly to 247,199 DKK, suggesting potential concerns regarding financial stability and operational efficiency. With limited information on its size and employee count, its position within the specialized medical industry remains unclear, but the recent financial trajectory indicates challenges that need addressing for sustainable growth.
AI-generated summary
Overview
- Company type
- APS
- Anpartsselskab
- Founded
- 17.1.2019
Details
- Capital
- 50.000 kr.
Purpose
Selskabets formål er at drive speciallægevirksomhed og virksomhed, der er naturligt forbundet hermed. eje anparter i et speciallægeselskab samt aktiviteter i tilknytning hertil.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 2.7 mio. | -13 t. | 1.9 mio. | 247 t. | 2 | |
History
Ownership
Management
Directors
Production units (1)
Similar companies
Companies in the same industry and area